CONTACTS
SUBJECTS
Default Null Subject Account for Blank Record
0403 -
0403 - ..
0404 - Summary/Objective
0405 -
040501 - Follow up ref SDS 56 0000. ref SDS 54 0000.
040502 -
040503 -
040504 -
040506 - ..
0406 -
0407 -
0408 - Progress
0409 -
040901 - Background...
040902 -
040903 - 1. On 090108 examination at UCSF showed possible progression of
040904 - IBC in breastbone area. Millie reported severe side effects.
040905 - Medical team prescribed another cycle sunitinib treatment, with
040906 - paused until blood counts to a safe level.
040908 - ..
040909 - 2. On 090108 Millie received a letter from Glenna summarizing
040910 - understandings for the work plan presented during the meeting
040911 - earlier at UCSF on 090108. ref SDS 49 LX7O
040913 - ..
040914 - 3. On 090109, Millie submitted a letter to the medical team
040915 - presenting findings from the examination and transmitting
040916 - Glenna's work plan summary. ref SDS 50 UC4H
040918 - ..
040919 - 4. On 090116 Glenna called about Millie's response to sunitinib
040920 - treatments. during 3rd cycle of sunitinib. ref SDS 56 JY6L
040921 - Reviewed record on 090115 reporting IBC rash looks improved to
040922 - stable, and nodules in the breastbone area seem stable to
040923 - worse, ref SDS 54 124N, relative to detailed review on 090110,
040924 - ref SDS 51 124N, and after 7 days of treatment with only
040925 - sunitinib, and 21 total treatments with sunitinib since the
040926 - pause on 081218 and resuming on 081226, ref SDS 54 6C4J,
040928 - ..
040929 - 5. Millie talked on 090116 in the morning about reducing the dose
040930 - of sunitinib in order to reduce side effects. ref SDS 56 JY7J
040931 - She seems at this point still committed to trying the current
040932 - higher dose in order to optimize recovery, planned in the
040933 - meeting with the medical team on 090108, noted in Millie's
040934 - letter on 090109. ref SDS 50 UF3T
040936 - ..
040937 - 6. Asked Glenna about remedy to relieve side effects, mainly of
040938 - sore toes that prevent exercise that maintains immune system
040939 - for recoverying from cancer. ref SDS 56 PPUQ
040941 - ..
040942 - 7. On 090116 Millie received Glenna's letter planning a meeting
040943 - with Doctor Rugo to discuss a treatment plan for progression of
040944 - cancer, ref SDS 58 YN9H, and which attached a letter Glenna
040945 - sent to the doctor describing IBC in the breastbone area has
040946 - worsened. ref SDS 58 FW3J
040948 - ..
040949 - 8. On 090116 Millie's letter to Glenna clarifies breastbone area
040950 - looks stable to worse; everything else looks improved to
040951 - stable. ref SDS 59 IS6G Millie further reports rising side
040952 - effects of treatment, and requests remedy. ref SDS 59 IT4V
040954 - ..
040955 - 9. On 090118 Millie talks about wanting to end treatment with
040956 - sunitinib that seems now less effective and has severe side
040957 - effects after adding cycloposphamide. ref SDS 60 UC41
040959 - ..
040960 - Glenna asks again today about Millie's response to treatment following
040961 - up her call on 090116, ref SDS 56 JY6L, and per background above.
040962 - ref SDS 0 JY5I
040964 - ..
040965 - Reviewed the record of patient history on 090120 reporting IBC rash
040966 - looks stable to worse, and nodules in the breastbone area seem worse,
040967 - ref SDS 62 124N, relative to detailed review on 090110, ref SDS 51
040968 - 124N, and after 11 days of treatment with only sunitinib, and 25 total
040969 - treatments with sunitinib, since the pause on 081218 and resuming on
040970 - 081226, shown below. ref SDS 61 6C4J
040972 - ..
040973 - Worsening IBC in breastbone area that has progressed onto the right
040974 - breast and spread toward the left chest reflects rising cancer marker;
040975 - Labs at Kaiser on 090116 report CA 15-3 303. ref SDS 57 PQTQ
040977 - ..
040978 - This record indicates Millie has suffered progression, which is the
040979 - 6th relapse of IBC.
040980 -
040981 - [On 090122 2321 telephone message from Glenna says Doctor
040982 - Rugo diagnoses 7th relapse, ends treatment on sunitinib;
040983 - plans meeting to prescribe next treatment. ref SDS 67 J47F
040985 - ..
040986 - [On 090122 2321 case study shows Millie suffers 7th relapse
040987 - of cancer. ref SDS 67 J34U
040989 - ..
040990 - Glenna asked for the 5 most severe side effects of Sunitinib?
040992 - ..
040993 - Patient history on 090120 shows continuing fatigue, ref SDS 62 KL4J,
040994 - cited on 090116, ref SDS 55 KL4J, pain in feet and mostly toes,
040995 - ref SDS 61 HY8M, and muscle weakness in the legs, reported on 090111.
040996 - ref SDS 52 3E4K Millie's legs tire quickly, ref SDS 61 3E4K, cited
040997 - previously on 090102. ref SDS 45 6E7G Joint pain, discomfort, and
040998 - total ill feeling, commonly associated with chemotherapy, reported on
040999 - 081218, ref SDS 37 E38H, and discussed with the medical team at UCSF
041000 - also on 081218, ref SDS 38 QW7H, has now returned after just 3
041001 - chemotherapy treatments with cyclophosphamide, shown in patient
041002 - history. ref SDS 62 E38H
041003 -
041004 -
041006 - ..
041007 - Medical Team Requests Support Doctor Patient Partnership
041008 - Treatment Strategy UCSF Planning Millie's Care After Sunitinib
041009 -
041010 - Glenna advised that she met with Doctor Rugo today. The doctor asked
041011 - her to call the [patient assistant - Rod] for help finding treatments
041012 - to aid UCSF planning for Millie to continue recovery from cancer. The
041013 - doctor wants Millie to check the SDS record for treatments UCSF has
041014 - identified to treat Millie's cancer as a "chronic disease." Glenna
041015 - explained that Millie's patient profile requires "targeted" treatments
041016 - lined up to maintain local control. This implements Doctor Johnson's
041017 - instructions the past few months, and recently during the meeting at
041018 - Kaiser on 081219 1140, for UCSF to identify future treatments for
041019 - timely care of additional relapses. ref SDS 40 V93O
041021 - ..
041022 - We reviewed the record on 081016, when Doctor Rugo advised that UCSF
041023 - has targeted drugs lined up for providing care of future relapses in
041024 - time to be effective controlling Millie's cancer. ref SDS 30 NW6M
041026 - ..
041027 - Glenna explained that UCSF has lost the list of therapies which Doctor
041028 - Rugo planned for treating Millie's cancer as a chronic disease.
041030 - ..
041031 - Glenna recalled that Brigid attended the meeting on 081016, and she
041032 - left UCSF for military duty. Megan may have been involved, but she
041033 - transferred out of the Department. As a result, nobody can find what
041034 - Doctor Rugo was planning for Millie.
041036 - ..
041037 - [On 090123 1326 Millie's primary care physician at
041038 - Kaiser, Doctor Johnson, called and advised again that
041039 - Millie's cancer has mutated to resist treatments
041040 - available at Kaiser, and so Millie should notify Doctor
041041 - Rugo that Kaiser authorizes treatment at UCSF, which
041042 - must be planned to start quickly in time to be effectve
041043 - for Millie's patient profile. ref SDS 69 8K6K
041045 - ..
041046 - Glenna said that finding details to assemble UCSF's treatment plans
041047 - for Millie is hard work that takes a lot of time. Since Millie has
041048 - survived cancer for a long time, her medical records expanding into
041049 - 8-years of treatment are very complex, noted previously by doctors on
041050 - Millie's medical team in case study on 061020. ref SDS 21 T25H
041051 - Information gets mixed up and misplaced due to rising confusion and
041052 - limited time, explained in NWO on advantages of a "well ordered
041053 - record." ref OF 12 RX4K This aligns with Doctor Rugo frustration from
041054 - difficulty finding information in Millie's medical chart at UCSF
041055 - during the meeting on 080219. ref SDS 26 L18L
041057 - ..
041058 - [On 090123 1326 Doctor Johnson complimented Doctor Rugo
041059 - for proactive case management getting a list for
041060 - treating Millie's cancer as a chronic disease.
041061 - ref SDS 69 VK6O
041063 - ..
041064 - [On 090202 1011 Doctor Rugo advises medical team that a
041065 - simple prescription is inadequate, ref SDS 76 278T, for
041066 - comprehensive care required to treat Millie's complex
041067 - patient profile, later listed on 090213, during meeting
041068 - with Doctor Johnson at Kaiser. ref SDS 79 ES7I
041070 - ..
041071 - [On 100301 0005 medical team has still not analyzed
041072 - trade-offs on alternative cancer treatments because this
041073 - takes "yeoman's work." ref SDS 94 OO9P
041075 - ..
041076 - Millie faced similar problems at her firm, Nixon Peabody on 960406.
041077 - She was asked to help people in another department find information on
041078 - a major case which had been misfiled by an attorney. ref SDS 1 5922
041079 - Research at that time showed finding critical details is a problem for
041080 - everybody. ref SDS 1 4249 Later on 031211, Millie's boss stored
041081 - information "behind the cupboard" because the filing cabinet was full.
041082 - Remembering where information was stored in that case demonstrated
041083 - superior intelligence. ref SDS 9 5B96
041085 - ..
041086 - Glenna said today that Doctor Rugo is concerned that Millie needs to
041087 - change treatments very soon in order to continue controlling her
041088 - cancer. The doctor feels experience the past 2 years shows the
041089 - patient has a well ordered record of medical history that helps find
041090 - critical details for planning Millie's next treatment. Glenna cited
041091 - the "work plan" on 081016 for starting sunitinib treatment shows
041092 - complex work in progress can be organized and managed effectively.
041093 - SDS provides a well ordered record of patient history that enables
041094 - finding details in time to be effective. ref SDS 30 J36R As a result,
041095 - Doctor Rugo asked Glenna to ask Millie for help this morning to find
041096 - the various treatments which UCSF has planned for Millie's next
041097 - relapse.
041099 - ..
041100 - [On 090203 Doctor Al-Bussam said Millie's paitient
041101 - history is very complicated, and SDS record is well
041102 - organized that helped his review to prescribe treatment
041103 - in time to be effective. ref SDS 73 JZ4F
041105 - ..
041106 - [On 090206 Doctor Stritter cited patient longevity
041107 - surprising for IBC, and credits good case management.
041108 - ref SDS 78 7Q7J
041110 - ..
041111 - [On 090514 0830 during a meeting at UCSF, Doctor Rugo
041112 - asked for help again on Millie's patient history, and
041113 - noted that Millie's records cited in communication with
041114 - the medical team are very detailed. ref SDS 86 LS5M
041116 - ..
041117 - Requesting patient support today aligns with Doctor Rugo's request on
041118 - 080403 for assistance coordinating with Kaiser on referral case
041119 - management. ref SDS 28 4U9O
041120 -
041122 - ..
041123 - Treatment Planning List UCSF Proposals for Millie's Future Treatments
041124 - Treating Millie's Cancer as Chronic Disease UCSF Drugs Proposed
041125 -
041126 - As requested by Doctor Rugo, per above, ref SDS 0 Y67L, during the
041127 - call today we reviewed background in the SDS record on UCSF planning
041128 - for Millie's next treatment after sunitinib.
041129 -
041130 - 1. On 041117 Doctor Rugo's colleague, Doctor Benz, submitted a
041131 - 2nd opinion to Kaiser listing treatments for Millie...
041133 - ..
041134 - a. Bevacizumab (Avastin) and Taxol....... ref SDS 13 OU5P
041135 - b. Bevacizumab (Avastin) and Tarceva..... ref SDS 13 OV3T
041136 - c. Capecitabine.......................... ref SDS 13 OU5V
041137 - d. Capecitabine with Taxotere............ ref SDS 13 OU6S
041138 - ** e. liposomal anthracycline
041139 - known as Doxil........................ ref SDS 13 OU5V
041140 - e. Gemzar with Taxotere.................. ref SDS 13 OU6S
041141 - f. small molecule kinase inhibitors
041142 - as part of a protocol would certainly
041143 - be warranted.......................... ref SDS 13 OU6W
041145 - ..
041146 - ** Note: on 090129 Doctor Rugo proposed Doxil with
041147 - hyperthermia in a letter to Kaiser, reported the next day
041148 - on 090130. ref SDS 71 HK3V
041150 - ..
041151 - 2. On 060929 Doctor Rugo's colleague, Doctor Benz, submitted
041152 - another 2nd opinion to Kaiser listing possible treatments
041153 - for Millie...
041154 -
041155 - ** a. Cetuximab with carboplatin............ ref SDS 20 UI9K
041156 - g. Abraxane with lapatinib............... ref SDS 20 UI9K
041157 - h. Navelbine............................. ref SDS 20 WR3Y
041158 - i. Navelbine with capecitbine............ ref SDS 20 WR3Y
041159 - j. Gemzar................................ ref SDS 20 WR3Y
041160 - k. Gemzar with capecitabine.............. ref SDS 20 WR3Y
041162 - ..
041163 - ** Note: Millie was successfully treated with cetuximab
041164 - and carboplatin for 2 years, beginning on 070201.
041166 - ..
041167 - Note: Doctor Benz appears to amend the first 2nd opinion
041168 - received on 041117, saying in the follow up opinion...
041169 -
041170 - In my opinion, it is less likely she would receive much
041171 - benefit from newer formulations of anthracyclines or
041172 - taxanes which she has already received, such as Doxil
041173 - or Abraxane.
041174 -
041175 - [On 090129 Doctor Rugo proposed Doxil with
041176 - hyperthermia in a letter to Kaier, reported the next
041177 - day on 090130. ref SDS 71 HK3V
041179 - ..
041180 - 3. On 061230 Doctor Rugo proposed in a letter to Kaiser that
041181 - Millie might benefit from treatment at UCSF with
041182 - bevacizumab and abraxane. ref SDS 23 JP5V
041184 - ..
041185 - 4. On 070130 Doctor Rugo seemed to indicate Millie qualifies
041186 - for treatment with other drugs in clinical study at UCSF,
041187 - ref SDS 24 TG5G, noted previously by Doctor Benz in a
041188 - letter dated 060821, and reviewed at Kaiser on 060929.
041189 - ref SDS 20 UI9K This was discussed again at Kaiser on
041190 - 061208, ref SDS 22 P256, leading to Kaiser's referral for
041191 - Millie's treatment at UCSF on 061230. ref SDS 23 PN5X
041193 - ..
041194 - 5. On 070130 during a meeting at UCSF Doctor Rugo discussed
041195 - again treatment for Millie with bevacizumab and Abraxane,
041196 - and seemed to indicate that diagnosis of pulmonary embolism
041197 - may not have been caused by bevacizumab. ref SDS 24 LD6Y
041199 - ..
041200 - 6. On 081016 the doctor seemed to say that a new study would
041201 - be starting in about 4 months that can help Millie, and
041202 - proposed interim treatment with sunitinib, and further
041203 - indicated that UCSF has other treatments targeted to help
041204 - Millie recover from IBC. ref SDS 30 J35X
041205 -
041206 - [On on 090130 Millie's letter to the medical team
041207 - reports that on 090129 Doctor Rugo prescribed treating
041208 - Millie with hyperthermia in the Radiation Oncology
041209 - Department at UCSF, and in order to establish local
041210 - control of expanding IBC, following relapse during
041211 - treatment with sunitinib study. ref SDS 71 AY9Q
041213 - ..
041214 - 7. On 090108 the doctor again indicated other treatments and
041215 - studies are avilable at UCSF, cited in Millie's letter to
041216 - the medical team on 090109. ref SDS 50 UC4H
041218 - ..
041219 - During the call today, Glenna explained that she prepared another
041220 - letter to Doctor Rugo presenting patient status, per above,
041221 - ref SDS 0 AJ3J, Glenna said that she will meet with the doctor later
041222 - today about follow on treatments for Millie to recover from her 6th
041223 - relapse of IBC, per above, ref SDS 0 Y67L, as planned in Glenna's
041224 - letter on 090116. ref SDS 58 YN9H
041226 - ..
041227 - [On 090122 called Glenna from Kaiser Emergency Department to
041228 - report Millie's shoulder injury; left message asking about
041229 - results of Glenna's meeting with Doctor Rugo. ref SDS 66 YT7J
041231 - ..
041232 - [On 090122 telephone message from Glenna reporting she met with
041233 - Doctor Rugo to develop treatment plan for Millie, and schedules
041234 - Millie to start new treatment on 090129. ref SDS 67 K96F
041236 - ..
041237 - [On 090123 Millie's letter to medical team reports progress at
041238 - UCSF scheduling Millie to start on a new treatment. ref SDS 68
041239 - KR4P
041241 - ..
041242 - [On 090123 1326 Doctor Johnson called was pleased that UCSF is
041243 - implementing his many requests for UCSF to prescribe Millie's
041244 - next treatment (e.g., see on 081219 1140, ref SDS 40 KU6F,
041245 - because after multiple relapses Millie' cancer has mutated into
041246 - a very aggressive disease that requires immediate treatment.
041247 - ref SDS 69 RK6O
041249 - ..
041250 - [On 090127 Millie's letter notified medical team that primary
041251 - care physician approves UCSF prescribing treatment for Millie's
041252 - 6th relapse from IBC, because recent rise of cancer marker CA
041253 - 15-3 303 for the labs at Kaiser on 090116 indicated Millie's
041254 - cancer has mutated to cells that now resist treatments
041255 - available at Kaiser. ref SDS 70 TY5W
041257 - ..
041258 - [On 090127 1344 Millie's letter to medical team submitted list
041259 - of prospective treatments previously presented by UCSF,
041260 - ref SDS 70 TY6S, and requested by Glenna for review with Doctor
041261 - Rugo on 090121 (today, per above. ref SDS 0 Y67L
041263 - ..
041264 - [On 090127 Millie's letter to medical team reported side
041265 - effects of sunitinib treatment begin to subside 5 days after
041266 - UCSF ended treatment with the sunitinib protocol. ref SDS 70
041267 - TY8T
041269 - ..
041270 - [On 090129 0800 Doctor Rugo wrote a letter to Kaiser explaining
041271 - next treatment with hyperthermia and Doxil for Millie to
041272 - recover from 6th relapse of IBC, cited in Millie's letter to
041273 - the medical team on 090130.
041275 - ..
041276 - [On 090204 0219 Millie requests planning from Doctor Rugo at
041277 - UCSF showing strategy and drug options for treating Millie's
041278 - cancer as a chronic disease, ordered by Doctor Johnson at
041279 - Kaiser. ref SDS 74 278T
041281 - ..
041282 - [On 090204 1747 Millie received list of 10 additional
041283 - treatments targeted for Millie's patient profile, so there is a
041284 - list of drugs to treat Millie's cancer as a chronic disease, as
041285 - recommended by Doctor Johnson. ref SDS 75 4R3S
041287 - ..
041288 - [On 090205 0830 Doctor Hsu changed Millie's treatment to
041289 - radiation with hyperthermia because delaying treatment caused
041290 - Millie's cancer to become too severe to recover with
041291 - hyperthermia and Doxil. ref SDS 77 EY5F
041293 - ..
041294 - [On 090218 0828 received follow up letter from Gwen submitting
041295 - article on Thermodox used with hyperthermia. ref SDS 80 7Q7J
041297 - ..
041298 - [On 090220 1548 paper received from UCSF on hyperthermia
041299 - explains options combining with chemotherapy, ref SDS 82 0129,
041300 - and biological vaccines. ref SDS 82 0164
041302 - ..
041303 - [On 090312 0830 meeting with Tara says Doctor Rugo planning
041304 - treatments for Millie after radiation and hyperthermia.
041305 - ref SDS 83 SS4F
041307 - ..
041308 - [On 090312 0830 Doctor Hsu advises UCSF Radiology Oncology
041309 - Department has more treatments that can help Millie recover
041310 - from IBC, ref SDS 83 F973; this includes combining hyperthermia
041311 - with a new form of Doxil, ref SDS 83 T95N, and also the use of
041312 - vaccines with hyperthermia. ref SDS 83 F991
041314 - ..
041315 - [On 090514 0830 Doctor Rugo explained a number of treatments
041316 - becoming available at UCSF targeted to Millie's patient
041317 - profile, including triple negative, and which can treat
041318 - Millie's cancer as a chronic disease, as ordered by Doctor
041319 - Johnson at Kaiser. ref SDS 86 YW48
041321 - ..
041322 - [On 090514 0830 Doctor Rugo prescribed MPA as the first new
041323 - treatment targeted to treat Millie's triple negative status.
041324 - ref SDS 86 D647
041326 - ..
041327 - [On 090528 1238 Millie re-submitted comprehensive list of
041328 - treatments cited by the medical team targeted to Millie's
041329 - patient profile for treating her cancer as a chronic disease,
041330 - ref SDS 87 4N5U, as shown in the record on 090121, ref SDS 0
041331 - EV53, and including clinical trials researched on 090204 1523,
041332 - ref SDS 75 4R3S, and submitted to the medical team on 090326
041333 - 0054, at the request of Doctor Johnson, the primary care
041334 - physician at Kaiser. ref SDS 85 DW5S
041336 - ..
041337 - [On 090616 0830 Doctor says everybody at Kaiser and UCSF is on
041338 - board for treating Millie's cancer as a chronic disease, and
041339 - says the medical team plans on Millie's next treatment in
041340 - September will apply PARP technology. ref SDS 88 KD6L
041342 - ..
041343 - [On 090701 1652 Doctor Hsu reports he has another treatment
041344 - for Millie's symptoms of tightness on her left side.
041345 - ref SDS 89 4P51
041346 -
041347 -
041349 - ..
041350 - Patient history...
041351 -
041352 -
041353 - 1. Summary
041354 -
041355 - Millie is being treated at UCSF on referral from Kaiser for
041356 - 5th relapse of secondary IBC. She was diagnosed with
041357 - breast cancer on 020321 from biopsy performed 020304.
041358 - ref SDS 3 MA5K IBC symptoms were reported in PET scan test
041359 - 10 months later on 021218, reviewed at Kaiser on 030109.
041360 - ref SDS 8 L66M Symptoms were diagnosed and treated as
041361 - Cellulitis. ref SDS 8 KW5F This persisted through 2003.
041362 - During that period, Millie received no treatment.
041363 - Secondary IBC was diagonsed with biopsy on 040419, shown in
041364 - pathology report received from Kaiser on 040517.
041365 - ref SDS 11 7D6F
041366 -
041367 - [On 090203 Millie's patient history submitted to VCI for
041368 - review to expedite planning of hyperthermia treatment
041369 - needed in time to be effective for recovering from
041370 - Millie's 6th relapse of IBC. ref SDS 72 EO5Q
041372 - ..
041373 - [On 090206 Doctor Stritter cited patient longevity
041374 - surprising for IBC credits case management. ref SDS 78
041375 - 7Q7J
041377 - ..
041378 - [On 090127 1344 Millie's letter submitted with link to
041379 - this record patient history for planning follow up
041380 - treatment. ref SDS 70 TY6X
041382 - ..
041383 - In 7 years of treatment Millie has not been diagnosed with
041384 - distant metastasis other than axillary and supraclavicular
041385 - lymph nodes, which are symptoms of IBC. (see patient
041386 - history of image tests listed on 081112, ref SDS 32 GM3N
041387 - In effect, she only has IBC.
041389 - ..
041390 - Pulmonary embolism was diagnosed with CT test on 041103,
041391 - reported at Kaiser the next day on 041104. Millie was
041392 - removed from treatment on clinical study with bevacizumab
041393 - and Taxol. ref SDS 12 RZ4I Kaiser delayed treatment of IBC
041394 - for 3 months while searching for another clinical trial to
041395 - treat Millie. Millie was treated again with another 4
041396 - cycles of AC beginning on 050104. ref SDS 14 407N
041398 - ..
041399 - Triple negative status (ER, PR, HER2 neu all negative)
041400 - originally diagnosed on 020321 citing core biopsy on
041401 - 020304. ref SDS 3 6Q6J This was recently confirmed as
041402 - unchanged with follow up core biopsy ordered by Doctor Rugo
041403 - and performed at Kaiser on 081107; results reported triple
041404 - negative on 081119. ref SDS 34 5O8G
041405 -
041407 - ..
041408 - 2. Laboratory Blood Tests...
041409 -
041410 - Millie has extensive blood testing, currently every 3 weeks
041411 - at UCSF, but weekly for the past 2 years. Occassionally,
041412 - there are backup labs at Kaiser.
041414 - ..
041415 - On 090108 labs at UCSF start 3rd cycle sunitinib protocol.
041416 - ref SDS 47 075H
041418 - ..
041419 - On 090116 labs at Kaiser show WBC 5.2 rising for first
041420 - time, ref SDS 57 OT8J, but cancer marker CA 15-3 303
041421 - indicates Millie suffering 6th relapse of IBC. ref SDS 57
041422 - PQTQ
041423 -
041424 - [On 090122 partial lab CBC without Diff at Kaiser in ER
041425 - for treatment dislocated shoulder. ref SDS 66 S65I
041426 -
041428 - ..
041429 - 3. Image tests show no evidence distant metastasis in 7 years,
041430 - listed on 081112... ref SDS 32 GM3N
041431 -
041432 - Millie had a CT test on 081230; results received on
041433 - 090107 show no significant change. ref SDS 46 GM3N
041434 -
041436 - ..
041437 - 4. Treatment history...
041438 -
041439 - Left breast sentinel node procedure
041440 - and left axilary disection and
041441 - left breast lumpectomy........... 020312, ref SDS 2 Q78M
041443 - ..
041444 - AC 2 cycles...................... 020423, ref SDS 4 0001
041445 - Taxotere 2....................... 020610, ref SDS 5 MR5I
041446 - Radiation........................ 020924, ref SDS 6 0J7H
041447 - Taxotere 2 (total 4)............. 021204, ref SDS 7 F5Z5
041449 - ..
041450 - Bevacizumab Taxol 7.............. 040420, ref SDS 10 9Z5J
041451 - AC 4 (total 6)................... 050104, ref SDS 14 407N
041453 - ..
041454 - Capacitabine and Taxotere 8...... 050329, ref SDS 15 T58M
041455 - completed...................... 050916, ref SDS 16 407N
041457 - ..
041458 - Mastectomy left breast........... 051021, ref SDS 17 EG5L
041460 - ..
041461 - Relapse cancer...
041462 - Capacitabine and Taxotere 7
041463 - (total 15)....................... 060721, ref SDS 19 407N
041465 - ..
041466 - Cetuximab (total 90)............. 070201, ref SDS 25 G68I
041467 - Carboplatin and cetuximab 21..... 080313, ref SDS 27 4E9N
041469 - ..
041470 - Sunitinib (daily)................ 081114, ref SDS 33 506F
041471 - Cyclophosphamide Methotrexate.... 081128, ref SDS 36 PA8Y
041472 - Sunitinib Cyclophosphamide
041473 - paused........................... 081219, ref SDS 39 716I
041474 - Methotrexate ended............... 081219, ref SDS 39 716I
041475 - ..
041476 - Sunitinib Cyclophosphamide
041477 - resumed.......................... 081226, ref SDS 43 505G
041478 - Sunitinib only
041479 - Cyclophosmphamide paused
041480 - 1 week........................... 090109, ref SDS 50 UF3Q
041482 - ..
041483 - Sunitinib treatment ended due
041484 - to rising symptoms of 6th
041485 - relapse IBC...................... 090122, ref SDS 67 K96F
041487 - ..
041488 - Radiation and hyperthermia for
041489 - 6th relapse IBC started getting
041490 - 4 treatments per week............ 090219, ref SDS 81 E57G
041491 - Treatment ended after 4
041492 - weeks............................ 090317, ref SDS 84 9L7K
041494 - ..
041495 - MPA clinical trial at UCSF
041496 - begins........................... 090616, ref SDS 88 D647
041498 - ..
041499 - MPA ends due to concerns about
041500 - effectiveness, and possibility of
041501 - causing another pulmonary
041502 - embolism which could
041503 - be fatal......................... 090716, ref SDS 91 YG8Y
041505 - ..
041506 - Gemzar treatment started at
041507 - Kaiser........................... 090728, ref SDS 92 W65H
041509 - ..
041510 - Navelbine started at
041511 - Kaiser........................... 091118, ref SDS 93 625I
041513 - ..
041514 - Abraxane started at
041515 - Kaiser........................... 100303, ref SDS 95 625I
041516 -
041518 - ..
041519 - Treatment Strategy Considerations...
041520 -
041521 - After 5 relapses, Millie's cancer has mutated to resist single-agent
041522 - chemotherapy drugs, noted by primary care physician on 080829, cited
041523 - in the letter to the medical team at that time. ref SDS 29 RP9R This
041524 - issue was presented with 2nd opinion research on 060721. ref SDS 18
041525 - RQ5N
041527 - ..
041528 - [On 090122 telephone message from Glenna reporting she met
041529 - with Doctor Rugo to develop treatment plan for Millie, and
041530 - schedules Millie to start new treatment on 090129.
041531 - ref SDS 67 K96F
041533 - ..
041534 - [On 090123 primary care physician advised that Millie's
041535 - cancer has mutated to cells that are resistant to
041536 - treatments available at Kaiser, and indicated UCSF has the
041537 - best chance of helping Millie. ref SDS 69 RK6O
041539 - ..
041540 - [On 090123 Millie's letter to medical team reports progress
041541 - at UCSF scheduling Millie to start on a new treatment.
041542 - ref SDS 68 KR4P
041544 - ..
041545 - [On 090127 Millie's letter notified medical team that
041546 - primary care physician approves UCSF prescribing treatment
041547 - for Millie's 6th relapse from IBC, because recent rise of
041548 - cancer marker CA 15-3 303 for the labs at Kaiser on 090116
041549 - indicated Millie's cancer has mutated to cells that now
041550 - resist treatments available at Kaiser. ref SDS 70 TY5W
041552 - ..
041553 - [On 090127 1344 Millie's letter submitted with link to this
041554 - record patient history for planning follow up treatment.
041555 - ref SDS 70 TY6X
041556 -
041557 -
041558 -
041559 -
041560 -
041561 -
041562 -
041563 -
041564 -
0416 -